{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:26:22Z","timestamp":1778016382557,"version":"3.51.4"},"publisher-location":"Cham","reference-count":68,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030340247","type":"print"},{"value":"9783030340254","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-34025-4_20","type":"book-chapter","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T12:03:24Z","timestamp":1583323404000},"page":"389-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Animal Models to Study Cancer and Its Microenvironment"],"prefix":"10.1007","author":[{"given":"N.","family":"Mendes","sequence":"first","affiliation":[]},{"given":"P.","family":"Dias Carvalho","sequence":"additional","affiliation":[]},{"given":"F.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"S.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"A. R.","family":"Malheiro","sequence":"additional","affiliation":[]},{"given":"A.","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"J.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"S.","family":"Velho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1937-6448(08)01201-X","volume":"271","author":"JF Amatruda","year":"2008","unstructured":"Amatruda JF, Patton EE (2008) Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol 271:1\u201334. https:\/\/doi.org\/10.1016\/S1937-6448(08)01201-X","journal-title":"Int Rev Cell Mol Biol"},{"issue":"17","key":"20_CR2","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.15252\/embj.201490147","volume":"34","author":"N Antonio","year":"2015","unstructured":"Antonio N, B\u00f8nnelykke-Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T et al (2015) The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J 34(17):2219\u20132236. https:\/\/doi.org\/10.15252\/embj.201490147","journal-title":"EMBO J"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fcimb.2013.00103","volume":"3","author":"E Bangi","year":"2013","unstructured":"Bangi E (2013) Drosophila at the intersection of infection, inflammation, and cancer. Front Cell Infect Microbiol 3:103. https:\/\/doi.org\/10.3389\/fcimb.2013.00103","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"20_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41388-017-0018-x","volume":"37","author":"A Blomme","year":"2018","unstructured":"Blomme A, Van Simaeys G, Doumont G, Costanza B, Bellier J, Otaka Y et al (2018) Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene 37(9):1237\u20131250. https:\/\/doi.org\/10.1038\/s41388-017-0018-x","journal-title":"Oncogene"},{"issue":"1","key":"20_CR5","doi-asserted-by":"publisher","first-page":"14.26.1-14.26.2","DOI":"10.1002\/0471141755.ph1426s61","volume":"61","author":"Antonio Calles","year":"2013","unstructured":"Calles A, Rubio-Viqueira B, Hidalgo M (2013) Primary human non-small cell lung and pancreatic tumorgraft models\u2013utility and applications in drug discovery and tumor biology. Curr Protoc Pharmacol Chapter 14(1), Unitas 14.26\u201314.26.21. https:\/\/doi.org\/10.1002\/0471141755.ph1426s61","journal-title":"Current Protocols in Pharmacology"},{"issue":"15","key":"20_CR6","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1158\/0008-5472.CAN-15-0727","volume":"75","author":"JW Cassidy","year":"2015","unstructured":"Cassidy JW, Caldas C, Bruna A (2015) Maintaining tumor heterogeneity in patient-derived tumor Xenografts. Cancer Res 75(15):2963\u20132968. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0727","journal-title":"Cancer Res"},{"issue":"7","key":"20_CR7","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.21873\/anticanres.11707","volume":"37","author":"C Chao","year":"2017","unstructured":"Chao C, Widen SG, Wood TG, Zatarain JR, Johnson P, Gajjar A et al (2017) Patient-derived Xenografts from colorectal carcinoma: a temporal and hierarchical study of murine stromal cell replacement. Anticancer Res 37(7):3405\u20133412. https:\/\/doi.org\/10.21873\/anticanres.11707","journal-title":"Anticancer Res"},{"issue":"8","key":"20_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s12276-018-0115-0","volume":"50","author":"Y Choi","year":"2018","unstructured":"Choi Y, Lee S, Kim K, Kim S-H, Chung Y-J, Lee C (2018) Studying cancer immunotherapy using patient-derived Xenografts (PDXs) in humanized mice. Exp Mol Med 50(8):99. https:\/\/doi.org\/10.1038\/s12276-018-0115-0","journal-title":"Exp Mol Med"},{"issue":"1","key":"20_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"C-P Day","year":"2015","unstructured":"Day C-P, Merlino G, Van Dyke T (2015) Preclinical mouse cancer models: a maze of opportunities and challenges. Cell 163(1):39\u201353. https:\/\/doi.org\/10.1016\/j.cell.2015.08.068","journal-title":"Cell"},{"issue":"1","key":"20_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2013.219","volume":"22","author":"C Devaud","year":"2014","unstructured":"Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CPM et al (2014) Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy. Mol Ther 22(1):18\u201327. https:\/\/doi.org\/10.1038\/mt.2013.219","journal-title":"Mol Ther"},{"issue":"1","key":"20_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/0008-5472.CAN-17-2084","volume":"78","author":"P Dias Carvalho","year":"2018","unstructured":"Dias Carvalho P, Guimar\u00e3es CF, Cardoso AP, Mendon\u00e7a S, Costa \u00c2M, Oliveira MJ, Velho S (2018) KRAS oncogenic signaling extends beyond cancer cells to orchestrate the microenvironment. Cancer Res 78(1):7\u201314. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2084","journal-title":"Cancer Res"},{"issue":"12","key":"20_CR12","doi-asserted-by":"publisher","first-page":"e84236","DOI":"10.1371\/journal.pone.0084236","volume":"8","author":"Z Dong","year":"2013","unstructured":"Dong Z, Imai A, Krishnamurthy S, Zhang Z, Zeitlin BD, N\u00f6r JE (2013) Xenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: a pilot study. PLoS One 8(12):e84236. https:\/\/doi.org\/10.1371\/journal.pone.0084236","journal-title":"PLoS One"},{"issue":"4564","key":"20_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.7112116","volume":"217","author":"IJ Fidler","year":"1982","unstructured":"Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217(4564):998\u20131003","journal-title":"Science"},{"key":"20_CR14","first-page":"343","volume":"74","author":"HH Fiebig","year":"1984","unstructured":"Fiebig HH, Schuchhardt C, Henss H, Fiedler L, L\u00f6hr GW (1984) Comparison of tumor response in nude mice and in the patients. Behring Inst Mitt 74:343\u2013352","journal-title":"Behring Inst Mitt"},{"issue":"39","key":"20_CR15","doi-asserted-by":"publisher","first-page":"E8234","DOI":"10.1073\/pnas.1618389114","volume":"114","author":"R Fior","year":"2017","unstructured":"Fior R, P\u00f3voa V, Mendes RV, Carvalho T, Gomes A, Figueiredo N, Ferreira MG (2017) Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci USA 114(39):E8234\u2013E8243. https:\/\/doi.org\/10.1073\/pnas.1618389114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"20_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R (2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 18(1):70. https:\/\/doi.org\/10.1186\/s12943-019-0994-2","journal-title":"Mol Cancer"},{"issue":"12","key":"20_CR17","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","volume":"89","author":"X Fu","year":"1992","unstructured":"Fu X, Guadagni F, Hoffman RM (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89(12):5645\u20135649","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"20_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.immuni.2018.03.037","volume":"48","author":"K Ganesh","year":"2018","unstructured":"Ganesh K, Massagu\u00e9 J (2018) TGF-\u03b2 inhibition and immunotherapy: checkmate. Immunity 48(4):626\u2013628. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.037","journal-title":"Immunity"},{"issue":"3","key":"20_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","volume":"2","author":"LA Garraway","year":"2012","unstructured":"Garraway LA, J\u00e4nne PA (2012) Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov 2(3):214\u2013226. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0012","journal-title":"Cancer Discov"},{"issue":"7","key":"20_CR20","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.4049\/jimmunol.0902609","volume":"185","author":"JL Gnerlich","year":"2010","unstructured":"Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA et al (2010) Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 185(7):4063\u20134071. https:\/\/doi.org\/10.4049\/jimmunol.0902609","journal-title":"J Immunol"},{"issue":"1","key":"20_CR21","doi-asserted-by":"publisher","first-page":"9061","DOI":"10.1038\/srep09061","volume":"5","author":"D Grifoni","year":"2015","unstructured":"Grifoni D, Sollazzo M, Fontana E, Froldi F, Pession A (2015) Multiple strategies of oxygen supply in Drosophila malignancies identify tracheogenesis as a novel cancer hallmark. Sci Rep 5(1):9061. https:\/\/doi.org\/10.1038\/srep09061","journal-title":"Sci Rep"},{"issue":"3","key":"20_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309\u2013322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022","journal-title":"Cancer Cell"},{"issue":"1","key":"20_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"7","key":"20_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc2877","volume":"10","author":"J Heyer","year":"2010","unstructured":"Heyer J, Kwong LN, Lowe SW, Chin L (2010) Non-germline genetically engineered mouse models for translational cancer research. Nat Rev Cancer 10(7):470\u2013480. https:\/\/doi.org\/10.1038\/nrc2877","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"20_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0233","volume":"10","author":"M Hidalgo","year":"2011","unstructured":"Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B et al (2011) A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther 10(8):1311\u20131316. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0233","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"20_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C et al (2014) Patient-derived Xenograft models: an emerging platform for translational cancer research. Cancer Discov 4(9):998\u20131013. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0001","journal-title":"Cancer Discov"},{"key":"20_CR27","doi-asserted-by":"publisher","unstructured":"Hoover RG, Gullickson G, Kornbluth J (2012) Natural killer lytic-associated molecule plays a role in controlling tumor dissemination and metastasis. Front Immunol 3(393). https:\/\/doi.org\/10.3389\/fimmu.2012.00393","DOI":"10.3389\/fimmu.2012.00393"},{"issue":"4","key":"20_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A et al (2015) Stromal contribution to the colorectal cancer transcriptome. Nat Genet 47(4):312\u2013319. https:\/\/doi.org\/10.1038\/ng.3224","journal-title":"Nat Genet"},{"issue":"10","key":"20_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"JI Johnson","year":"2001","unstructured":"Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S et al (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84(10):1424\u20131431. https:\/\/doi.org\/10.1054\/bjoc.2001.1796","journal-title":"Br J Cancer"},{"issue":"1","key":"20_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung J, Seol HS, Chang S (2018) The generation and application of patient-derived Xenograft model for Cancer research. Cancer Res Treat 50(1):1\u201310. https:\/\/doi.org\/10.4143\/crt.2017.307","journal-title":"Cancer Res Treat"},{"issue":"5","key":"20_CR31","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1534\/g3.117.300327","volume":"8","author":"A Katigbak","year":"2018","unstructured":"Katigbak A, Robert F, Paquet M, Pelletier J (2018) Inducible genome editing with conditional CRISPR\/Cas9 mice. G3 (Bethesda) 8(5):1627\u20131635. https:\/\/doi.org\/10.1534\/g3.117.300327","journal-title":"G3 (Bethesda)"},{"issue":"10","key":"20_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1101\/pdb.top069906","volume":"2015","author":"CJ Kemp","year":"2015","unstructured":"Kemp CJ (2015) Animal models of chemical carcinogenesis: driving breakthroughs in Cancer research for 100 years. Cold Spring Harb Protoc 2015(10):865\u2013874. https:\/\/doi.org\/10.1101\/pdb.top069906","journal-title":"Cold Spring Harb Protoc"},{"issue":"2","key":"20_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15252\/emmm.201606857","volume":"9","author":"K Kersten","year":"2017","unstructured":"Kersten K, de Visser KE, van Miltenburg MH, Jonkers J (2017) Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med 9(2):137\u2013153. https:\/\/doi.org\/10.15252\/emmm.201606857","journal-title":"EMBO Mol Med"},{"key":"20_CR34","doi-asserted-by":"publisher","unstructured":"Kirchberger S, Sturtzel C, Pascoal S, Distel M (2017) Quo natas, Danio?-recent progress in modeling cancer in zebrafish. Front Oncol 7(186). https:\/\/doi.org\/10.3389\/fonc.2017.00186","DOI":"10.3389\/fonc.2017.00186"},{"issue":"9","key":"20_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.cji.0000436722.46675.4a","volume":"36","author":"MG Lechner","year":"2013","unstructured":"Lechner MG, Karimi SS, Barry-Holson K, Angell TE, Murphy KA, Church CH et al (2013) Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. J Immunother 36(9):477\u2013489. https:\/\/doi.org\/10.1097\/01.cji.0000436722.46675.4a","journal-title":"J Immunother"},{"issue":"2","key":"20_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/j.seminoncol.2014.02.004","volume":"41","author":"D Lindner","year":"2014","unstructured":"Lindner D (2014) Animal models and the tumor microenvironment: studies of tumor-host symbiosis. Semin Oncol 41(2):146\u2013155. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.02.004","journal-title":"Semin Oncol"},{"issue":"1","key":"20_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-pathol-011110-130330","volume":"6","author":"S Liu","year":"2011","unstructured":"Liu S, Leach SD (2011) Zebrafish models for cancer. Annu Rev Pathol 6(1):71\u201393. https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130330","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"20_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3978\/j.issn.2223-4292.2015.06.01","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yin T, Feng Y, Cona MM, Huang G, Liu J et\u00a0al (2015) Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant Imaging Med Surg 5(5):708\u2013729. https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2015.06.01","journal-title":"Quant Imaging Med Surg"},{"issue":"7693","key":"20_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"issue":"3","key":"20_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF00047755","volume":"7","author":"J Mattern","year":"1988","unstructured":"Mattern J, Bak M, Hahn EW, Volm M (1988) Human tumor xenografts as model for drug testing. Cancer Metastasis Rev 7(3):263\u2013284","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"20_CR41","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.3979","volume":"21","author":"MQ McCreery","year":"2015","unstructured":"McCreery MQ, Halliwill KD, Chin D, Delrosario R, Hirst G, Vuong P et al (2015) Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat Med 21(12):1514\u20131520. https:\/\/doi.org\/10.1038\/nm.3979","journal-title":"Nat Med"},{"issue":"1","key":"20_CR42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1871520616666160922165133","volume":"17","author":"N Mendes","year":"2017","unstructured":"Mendes N, Tortosa F, Valente A, Marques F, Matos A, Morais TS et al (2017) Vivo performance of a ruthenium-cyclopentadienyl compound in an Orthotopic triple negative breast Cancer model. Anti Cancer Agents Med Chem 17(1):126\u2013136","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"6","key":"20_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1242\/dmm.006908","volume":"4","author":"WO Miles","year":"2011","unstructured":"Miles WO, Dyson NJ, Walker JA (2011) Modeling tumor invasion and metastasis in Drosophila. Dis Model Mech 4(6):753\u2013761. https:\/\/doi.org\/10.1242\/dmm.006908","journal-title":"Dis Model Mech"},{"issue":"9\u201310","key":"20_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1242\/dmm.004747","volume":"3","author":"MC Mione","year":"2010","unstructured":"Mione MC, Trede NS (2010) The zebrafish as a model for cancer. Dis Model Mech 3(9\u201310):517\u2013523. https:\/\/doi.org\/10.1242\/dmm.004747","journal-title":"Dis Model Mech"},{"key":"20_CR45","doi-asserted-by":"publisher","unstructured":"Mirzoyan Z, Sollazzo M, Allocca M, Valenza AM, Grifoni D, Bellosta P (2019) Drosophila melanogaster: a model organism to study cancer. Front Genet 10(51). https:\/\/doi.org\/10.3389\/fgene.2019.00051","DOI":"10.3389\/fgene.2019.00051"},{"issue":"9","key":"20_CR46","doi-asserted-by":"publisher","first-page":"7152962","DOI":"10.1155\/2018\/7152962","volume":"2018","author":"J-P Parvy","year":"2018","unstructured":"Parvy J-P, Hodgson JA, Cordero JB (2018) Drosophila as a model system to study nonautonomous mechanisms affecting tumour growth and cell death. Biomed Res Int 2018(9):7152962\u20137152913. https:\/\/doi.org\/10.1155\/2018\/7152962","journal-title":"Biomed Res Int"},{"issue":"2\u20133","key":"20_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1242\/dmm.000950","volume":"1","author":"JC Pastor-Pareja","year":"2008","unstructured":"Pastor-Pareja JC, Wu M, Xu T (2008) An innate immune response of blood cells to tumors and tissue damage in Drosophila. Dis Model Mech 1(2\u20133):144\u2013154. discussion 153. https:\/\/doi.org\/10.1242\/dmm.000950","journal-title":"Dis Model Mech"},{"issue":"4","key":"20_CR48","doi-asserted-by":"publisher","first-page":"4258387","DOI":"10.1155\/2018\/4258387","volume":"2018","author":"HE Richardson","year":"2018","unstructured":"Richardson HE, Portela M (2018) Modelling cooperative tumorigenesis in Drosophila. Biomed Res Int 2018(4):4258387\u20134258329. https:\/\/doi.org\/10.1155\/2018\/4258387","journal-title":"Biomed Res Int"},{"issue":"7","key":"20_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc3950","volume":"15","author":"FJ S\u00e1nchez-Rivera","year":"2015","unstructured":"S\u00e1nchez-Rivera FJ, Jacks T (2015) Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer 15(7):387\u2013395. https:\/\/doi.org\/10.1038\/nrc3950","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"20_CR50","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/annonc\/mdw041","volume":"27","author":"MF Sanmamed","year":"2016","unstructured":"Sanmamed MF, Chester C, Melero I, Kohrt H (2016) Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. Ann Oncol 27(7):1190\u20131198. https:\/\/doi.org\/10.1093\/annonc\/mdw041","journal-title":"Ann Oncol"},{"issue":"9","key":"20_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrd2110","volume":"5","author":"NE Sharpless","year":"2006","unstructured":"Sharpless NE, Depinho RA (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5(9):741\u2013754. https:\/\/doi.org\/10.1038\/nrd2110","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"20_CR52","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/0300985812467471","volume":"50","author":"HR Shive","year":"2013","unstructured":"Shive HR (2013) Zebrafish models for human cancer. Vet Pathol 50(3):468\u2013482. https:\/\/doi.org\/10.1177\/0300985812467471","journal-title":"Vet Pathol"},{"issue":"11","key":"20_CR53","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/0008-5472.CAN-11-2786","volume":"72","author":"M Singh","year":"2012","unstructured":"Singh M, Murriel CL, Johnson L (2012) Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes. Cancer Res 72(11):2695\u20132700. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2786","journal-title":"Cancer Res"},{"issue":"17","key":"20_CR54","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","volume":"73","author":"D Siolas","year":"2013","unstructured":"Siolas D, Hannon GJ (2013) Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res 73(17):5315\u20135319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1069","journal-title":"Cancer Res"},{"issue":"6","key":"20_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1349-7006.2006.00208.x","volume":"97","author":"T Szatm\u00e1ri","year":"2006","unstructured":"Szatm\u00e1ri T, Lumniczky K, D\u00e9saknai S, Trajcevski S, H\u00eddv\u00e9gi EJ, Hamada H, S\u00e1fr\u00e1ny G (2006) Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97(6):546\u2013553. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00208.x","journal-title":"Cancer Sci"},{"issue":"10","key":"20_CR56","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1535-7163.MCT-06-0391","volume":"5","author":"BA Teicher","year":"2006","unstructured":"Teicher BA (2006) Tumor models for efficacy determination. Mol Cancer Ther 5(10):2435\u20132443. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0391","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"20_CR57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","volume":"9","author":"JJ Tentler","year":"2012","unstructured":"Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM et al (2012) Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9(6):338\u2013350. https:\/\/doi.org\/10.1038\/nrclinonc.2012.61","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"20_CR58","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1210\/en.2008-1057","volume":"150","author":"FE Utama","year":"2009","unstructured":"Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H (2009) Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells. Endocrinology 150(4):1782\u20131790. https:\/\/doi.org\/10.1210\/en.2008-1057","journal-title":"Endocrinology"},{"issue":"2","key":"20_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(02)00621-9","volume":"108","author":"T Dyke Van","year":"2002","unstructured":"Van Dyke T, Jacks T (2002) Cancer modeling in the modern era: progress and challenges. Cell 108(2):135\u2013144","journal-title":"Cell"},{"issue":"7","key":"20_CR60","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/1078-0432.CCR-06-0918","volume":"13","author":"L Varticovski","year":"2007","unstructured":"Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ et al (2007) Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res 13(7):2168\u20132177. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0918","journal-title":"Clin Cancer Res"},{"key":"20_CR61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0065-230X(10)06004-5","volume":"106","author":"JC Walrath","year":"2010","unstructured":"Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010) Genetically engineered mouse models in cancer research. Adv Cancer Res 106:113\u2013164. https:\/\/doi.org\/10.1016\/S0065-230X(10)06004-5","journal-title":"Adv Cancer Res"},{"issue":"2","key":"20_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stem.2007.11.002","volume":"2","author":"RM White","year":"2008","unstructured":"White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C et al (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2(2):183\u2013189. https:\/\/doi.org\/10.1016\/j.stem.2007.11.002","journal-title":"Cell Stem Cell"},{"issue":"3","key":"20_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jcm7030041","volume":"7","author":"JA Williams","year":"2018","unstructured":"Williams JA (2018) Using PDX for preclinical Cancer drug discovery: the evolving field. J Clin Med 7(3):41. https:\/\/doi.org\/10.3390\/jcm7030041","journal-title":"J Clin Med"},{"issue":"3","key":"20_CR64","doi-asserted-by":"publisher","first-page":"FSO271","DOI":"10.4155\/fsoa-2017-0136","volume":"4","author":"E Yada","year":"2018","unstructured":"Yada E, Wada S, Yoshida S, Sasada T (2018) Use of patient-derived xenograft mouse models in cancer research and treatment. Future Sci OA 4(3):FSO271. https:\/\/doi.org\/10.4155\/fsoa-2017-0136","journal-title":"Future Sci OA"},{"issue":"2","key":"20_CR65","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3892\/ijo.2013.1962","volume":"43","author":"L Yi","year":"2013","unstructured":"Yi L, Zhou C, Wang B, Chen T, Xu M, Xu L, Feng H (2013) Implantation of GL261 neurospheres into C57\/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells. Int J Oncol 43(2):477\u2013484. https:\/\/doi.org\/10.3892\/ijo.2013.1962","journal-title":"Int J Oncol"},{"issue":"11","key":"20_CR66","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-10-4563","volume":"71","author":"NP Young","year":"2011","unstructured":"Young NP, Crowley D, Jacks T (2011) Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis. Cancer Res 71(11):4040\u20134047. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4563","journal-title":"Cancer Res"},{"issue":"11","key":"20_CR67","doi-asserted-by":"publisher","first-page":"e0206223","DOI":"10.1371\/journal.pone.0206223","volume":"13","author":"JW Yu","year":"2018","unstructured":"Yu JW, Bhattacharya S, Yanamandra N, Kilian D, Shi H, Yadavilli S et al (2018) Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. PLoS One 13(11):e0206223. https:\/\/doi.org\/10.1371\/journal.pone.0206223","journal-title":"PLoS One"},{"issue":"10","key":"20_CR68","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1136\/gutjnl-2017-315201","volume":"67","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M, Tan SY et al (2018) Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 67(10):1845\u20131854. https:\/\/doi.org\/10.1136\/gutjnl-2017-315201","journal-title":"Gut"}],"updated-by":[{"DOI":"10.1007\/978-3-030-34025-4_24","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000}}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-34025-4_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T10:30:25Z","timestamp":1666002625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-34025-4_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030340247","9783030340254"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-34025-4_20","relation":{"correction":[{"id-type":"doi","id":"10.1007\/978-3-030-34025-4_24","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"5 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}